<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We examined whether <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> (PB) inhibited the <z:hpo ids='HP_0011009'>acute</z:hpo> extracellular release of <z:chebi fb="40" ids="18243">dopamine</z:chebi> that occurs in the striatum following the <z:hpo ids='HP_0003674'>onset</z:hpo> of ischemic injury in the gerbil model of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The cerebral dialysis technique was employed to monitor striatal extracellular <z:chebi fb="40" ids="18243">dopamine</z:chebi> concentrations before and after carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> while perfusing either a control solution of artificial cerebrospinal fluid (CSF) or a 1 mM solution of <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> in CSF (PB/CSF) </plain></SENT>
<SENT sid="2" pm="."><plain>During perfusion with CSF, extracellular <z:chebi fb="40" ids="18243">dopamine</z:chebi> increased from a baseline concentration of 0.40 +/- 0.09 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>) pmoles/10 minute collection interval to 30.0 +/- 9.0 pmoles/10 minutes after carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast, during perfusion with PB/CSF, <z:chebi fb="40" ids="18243">dopamine</z:chebi> levels increased from a baseline of 1.37 +/- 0.3 pmoles/10 minutes to 8.30 +/- 2.6 pmoles/10 minutes; this increase was significantly less than the increase in controls </plain></SENT>
<SENT sid="4" pm="."><plain>In animals with established <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, repeatedly alternating the perfusion fluid between CSF and PB/CSF demonstrated that <z:chebi fb="40" ids="18243">dopamine</z:chebi> concentrations were significantly increased with CSF alone and decreased with PB/CSF </plain></SENT>
<SENT sid="5" pm="."><plain>These findings demonstrate that <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> perfusion either before or following the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> inhibits extracellular release of <z:chebi fb="40" ids="18243">dopamine</z:chebi> in the striatum </plain></SENT>
<SENT sid="6" pm="."><plain>Inhibition of neurotransmitter release may, in part, be responsible for the protective effect of <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> in ischemic brain injury </plain></SENT>
</text></document>